What is the latest update in the healthcare AI market?

The healthcare AI market is moving fast, and Q1 2026 brought some of the biggest signals yet, from FDA rule changes to a $250 million fundraising round.

This blog post is our living summary of the most important updates in the healthcare AI market, and we refresh it every quarter so you always have the latest picture.

And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.

Summary table of the most important updates in the healthcare AI market

We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.

We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.

We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.

You can also get all the latest market news for the month here.

News	Category	Date	Source
FDA updated its guidance on clinical decision support and general wellness AI software	Regulations & Policies	Jan. 6, 2026	U.S. FDA
OpenEvidence raised $250M to build AI for doctors and claimed over 40% daily physician adoption	Fundraisings	Jan. 21, 2026	Business Wire
Eli Lilly and NVIDIA launched a $1B AI drug discovery lab over five years	Partnerships	Jan. 12, 2026	NVIDIA Investor Relations
OpenAI and the Gates Foundation launched a $50M healthcare AI pilot for 1,000 African clinics	Strategic Investments	Jan. 20, 2026	OpenAI
Aidoc won FDA clearance for a foundation-model clinical AI product covering 14 indications	Product launches	Jan. 21, 2026	PR Newswire
Hippocratic AI acquired Grove AI and expanded into life sciences with new leadership	M&A	Jan. 12, 2026	Business Wire
Qualified Health raised $125M Series B as health systems moved to enterprise AI platforms	Fundraisings	Mar. 25, 2026	PR Newswire
Tempus reported 83% quarterly revenue growth in its Q4 2025 results	Financial results	Feb. 24, 2026	Tempus
Tempus and Merck expanded their AI biomarker collaboration in a multi-year deal	Partnerships	Mar. 3, 2026	Tempus
Alaffia Health raised $55M to automate health-plan claims with agentic AI	Fundraisings	Feb. 3, 2026	Alaffia Health
EFF sued CMS for records on Medicare's AI prior-authorization experiment	Litigation	Mar. 25, 2026	EFF
Anterior raised $40M to push clinician-led AI deeper into payer workflows	Fundraisings	Feb. 12, 2026	Anterior

How is the healthcare AI market doing now?

How do we define the healthcare AI market?

We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.

We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.

We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.

This is also the definition we use in our report covering the healthcare AI market.

How big is the healthcare AI market in 2026?

We estimate the healthcare AI market at approximately $29 billion in 2026, based on published research estimates, our own bottom-up calculations, and several validation checks.

This is not a random guess, if you want to know how we have come up with this estimate, you can read our healthcare AI market size analysis here.

To put that in perspective, the healthcare AI market is now roughly the same size as the global cybersecurity software market (around $30 billion) and close to the CRM software market (around $32 billion).

The healthcare AI market scores 35 out of 100 on maturity (still early despite fast growth), 75 out of 100 on competitiveness (eight unicorns and hundreds of funded startups), and 85 out of 100 on fragmentation (over 1,000 FDA-authorized AI devices with no dominant player across segments).

How fast will the healthcare AI market grow in the future?

Most research firms agree on a growth rate of 37 to 38% per year through 2030, which is the realistic estimate we use for the healthcare AI market.

At that pace, the healthcare AI market should reach roughly $102 billion by 2030, and could grow to around $580 to $675 billion by 2036, representing a 20-times-plus increase over a decade.

For comparison, cloud computing grew at about 25% per year and cybersecurity at about 12% over similar periods, so the healthcare AI market is outpacing both by a wide margin.

What does current funding activity look like in the healthcare AI market?

Our team, who continually updates our healthcare AI market pitch deck, is keeping a close eye on the market and tracking key signals.

One of those signals is fundraising activity across startups. Each month, we refresh this page with a list of startups of the healthcare AI market that have raised funding, and we also publish a quarterly analysis here.

Is funding momentum accelerating or cooling in the healthcare AI market these days?

Q1 2026 saw several very large healthcare AI fundraising rounds, including OpenEvidence at $250 million and Qualified Health at $125 million, which signals that investor confidence in the healthcare AI market is accelerating, not cooling.

Compared to Q1 2025, when healthcare AI-specific VC was still ramping from a $500 million annual base, Q1 2026 already included over $470 million in disclosed rounds from just the biggest deals, suggesting year-over-year funding has grown significantly.

Average deal sizes in Q1 2026 were notably large, driven by mega-rounds like OpenEvidence's $250 million and Qualified Health's $125 million, but the quarter also included mid-size rounds like Alaffia Health at $55 million and Anterior at $40 million, showing funding is spreading across both large and smaller healthcare AI startups.

Which categories and business models are attracting capital in the healthcare AI market?

These categories and business models of the healthcare AI market are receiving important fundraising currently:

• Clinical AI for physicians: OpenEvidence raised $250M for doctor-facing AI, showing investors believe clinical workflow tools can scale nationally.
• Enterprise AI platforms for health systems: Qualified Health raised $125M as hospitals shift from buying point tools to full AI deployment platforms.
• Payer-side claims automation: Alaffia Health ($55M) and Anterior ($40M) both raised to automate health plan claims, reflecting strong demand for AI that saves payers money fast.

The pattern is clear: healthcare AI investors are favoring companies that can show measurable ROI or already have deep adoption with providers or payers.

Who's writing the most checks in the healthcare AI market?

These investors are being very active when it comes to fundraising in the healthcare AI market:

• NEA led Qualified Health's $125M Series B, reinforcing its position as a major growth-stage backer of enterprise healthcare AI platforms.
• The Gates Foundation backed both the OpenAI Horizon 1000 pilot and Siemens Healthineers' maternal health AI, focusing on global and public health applications.

The mix of traditional venture firms and philanthropic capital shows that healthcare AI is attracting a wider range of funders than most enterprise software categories.

Any big acquisitions or IPOs in the last three months in the healthcare AI market?

These are the big acquisitions and IPOs that happened recently in the healthcare AI market:

• Hippocratic AI acquired Grove AI in January 2026, expanding from patient-facing agents into life sciences with new executive hires and a BCG partnership.

No major IPOs happened in Q1 2026, but the Hippocratic AI deal shows that well-funded healthcare AI startups are already buying their way into adjacent markets.

How are companies in the healthcare AI market performing overall?

We are watching this market everyday, because we need to constantly update our pitch deck. Here is a couple of things we have noticed.

Are there any standout success metrics or financial results in the healthcare AI market?

Yes, Q1 2026 brought some impressive numbers from healthcare AI companies:

• Tempus reported Q4 2025 revenue of $367.2 million, up 83% year over year, making it one of the strongest public-company proof points for the healthcare AI market.
• OpenEvidence said more than 40% of U.S. physicians use its platform daily, across over 10,000 hospitals and medical centers, a very bold adoption claim for any healthcare AI product.

When a public company like Tempus can show 83% revenue growth and a startup like OpenEvidence claims national-scale adoption, the healthcare AI market is moving from hype to hard evidence.

Have there been any major partnerships in the healthcare AI market?

Yes, several big partnerships were announced in Q1 2026 in the healthcare AI market:

• Eli Lilly and NVIDIA announced a $1 billion AI drug discovery lab over five years, combining Lilly's R&D data with NVIDIA's computing stack in one of the largest pharma-AI deals ever.
• Tempus and Merck expanded their collaboration in a multi-year deal focused on AI-driven biomarker discovery and precision medicine.
• Tempus also partnered with Daiichi Sankyo on AI-driven biomarker work for an ADC oncology program, just weeks after its Merck deal.
• OpenAI and the Gates Foundation launched Horizon 1000, a $50 million pilot to bring healthcare AI to 1,000 clinics across Africa by 2028.

The fact that Tempus signed two major pharma deals in the same quarter suggests it is becoming a default AI partner for big pharma, not a one-off vendor.

Have there been any notable technology or infrastructure breakthroughs in the healthcare AI market?

Yes, there were a couple of meaningful product milestones in Q1 2026 in the healthcare AI market:

• Aidoc received FDA clearance for what it described as healthcare's first comprehensive foundation-model AI, combining 11 new indications with 3 existing ones in a single clinical product.
• Hospital for Special Surgery deployed agentic AI for patient scheduling and triage, working across web, text, and phone with human staff able to step in at any point.

Aidoc's clearance is especially important because it shows the FDA is willing to approve broad, multi-indication healthcare AI products, not just narrow single-use tools.

Have any companies restructured or shifted pricing or business model in the healthcare AI market?

We did not spot any major restructurings, pricing changes, or business model shifts during Q1 2026 in the healthcare AI market.

Are there any other notable wins or successes in the healthcare AI market?

Yes, a few other wins stood out in Q1 2026:

• Aidoc hired former AMA president Dr. Jesse Ehrenfeld as chief medical officer, adding heavyweight medical credibility to one of the leading clinical AI companies.
• Siemens Healthineers received Gates Foundation funding for maternal health AI designed to predict pre-eclampsia and anemia earlier in pregnancy using standard prenatal blood data.

These moves show that healthcare AI companies are investing in clinical credibility and global health impact, not just technical features.

What is the overall sentiment in the healthcare AI market right now?

Are there any notable recent opinion pieces, thought leadership about the healthcare AI market?

Yes, a few pieces of thought leadership stood out in Q1 2026:

• Bessemer Venture Partners published its State of Health AI 2026 report, arguing that healthcare AI companies are reaching $100 million and even $200 million in annual recurring revenue much faster than previous generations of health tech startups.

When a top-tier investor like Bessemer says the healthcare AI market is accelerating faster than old health tech, it sets expectations for how the whole category gets valued.

Are there any interesting and recent market research reports about the healthcare AI market?

Yes, one notable market research report was released in Q1 2026:

• Rock Health published its 2025 Consumer Adoption Survey, showing that 32% of U.S. adults have used AI chatbots for health information (up from 16% a year earlier), and 64% of those users do it weekly or more.

The Rock Health data suggests that consumers are pulling the healthcare AI market forward even while hospitals and payers still move carefully.

Have there been any regulatory changes, policy updates, or new compliance requirements in the healthcare AI market?

Yes, Q1 2026 brought meaningful regulatory activity in the healthcare AI market:

• The FDA updated its Clinical Decision Support Software guidance and its General Wellness guidance on January 6, 2026, changing where the regulatory line sits for healthcare AI tools used by clinicians and lower-risk wellness products.
• The EFF filed a FOIA lawsuit against CMS seeking records about WISeR, a multi-state Medicare program that uses AI to evaluate requests for medical care, arguing the public lacks basic information about how the system works.

Taken together, these two events show that the healthcare AI market is entering a new phase where both regulators and advocacy groups are actively shaping the rules of the game.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.